Matthew Crooks, MD
Pain Medicine · Scottsdale, AZNPI 1609914662
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 71.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $5,949 and has fallen 56.0% since, to $2,617 in 2025.
Across 313 payments — averaging $66.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$15K
- Medtronic$2K
- Vertiflex, Inc.$876
- Boston Scientific$798
- Lenoss Medical Inc$728
- Nevro Corp.$386
- plus $2K from 18 others
Across 2 payments — averaging $8611.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Scilex Pharmaceuticals Inc.$10K
- GRT US Holding, Inc.$8K
What the payments were for
- Consulting fees$4002%
- Travel & lodging$6243%
- Food & beverage$19,70995%
- Education$1061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 206 | $14,933 |
| Medtronic(2 entities) | 23 | $1,565 |
| Vertiflex, Inc. | 6 | $876 |
| Boston Scientific | 23 | $798 |
| Lenoss Medical Inc | 3 | $728 |
| Nevro Corp. | 8 | $386 |
| Nalu Medical, Inc. | 4 | $314 |
| Bioventus LLC | 2 | $227 |
| Saluda Medical Americas, Inc. | 14 | $221 |
| Arteriocyte Medical Systems, Inc. | 1 | $159 |
| Life Spine, Inc. | 2 | $128 |
| Xtant Medical Inc | 1 | $93 |
| SPR Therapeutics, Inc | 3 | $79 |
| Relievant Medsystems, Inc. | 1 | $59 |
| Painteq LLC | 2 | $59 |
| Biotronik NRO, Inc. | 3 | $56 |
| Foundation Fusion Solutions, LLC | 4 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Galen US Inc | 1 | $20 |
| Vertex | 1 | $20 |
| Radius Health, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$4,800
- Proclaim IPG$3,907
- Proclaim Family of SCS IPGs$2,531
- Superion ISS$693
- OsteoPearl$575
- Octrode SCS Leads$429
- Axium INS DRG IPG$337
- KYPHON Balloon Kyphoplasty$314
- Nalu Neurostimulation System$281
- GENERAL PAIN MANAGEMENT$266
- Proclaim DRG IPG$184
- CD HORIZON$178
- INCEPTIV$172
- AQUAMANTYS$170
- INTELLIS ADAPTIVESTIM$169
- ENSITE$162
- Magellan$159
- Access & Cavity Creation Kit$153
- Omnia$145
- INTELLIS$140
How this compares
$20,839 in reported general payments places this provider in the 85th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 73 | $688 |
| Diclofenac Sodium | 29 | $347 |
| Celecoxib | 20 | $318 |
| Pregabalin | 26 | $272 |
| Tizanidine Hcl | 29 | $202 |
| Cyclobenzaprine Hcl | 12 | $161 |
| Methylprednisolone | 18 | $128 |
| Duloxetine Hcl | 13 | $128 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $88 |
| Methocarbamol | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Scottsdale
- Tory McJunkinScottsdale$204K
- Vivek IyerScottsdale$70K
- Avijit SharmaScottsdale$23K
- Natalie StrandScottsdale$22K
- Jason JensenScottsdale$21K
- Nikesh SethScottsdale$15K
- Ashu GoyleScottsdale$10K
- Monica TorresScottsdale$8K
- Eric CornidezTucson$496K
- Minesh ZaveriPhoenix$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.